Brief: Reviva Pharmaceuticals Holdings Inc Files Non-Timely 10-K With The U.S. SEC- SEC Filing
02/04/2024 18:37
April 2 (Reuters) - Reviva Pharmaceuticals Holdings Inc
RVPH.O :
* REVIVA PHARMACEUTICALS HOLDINGS, INC. FILES NON- TIMELY
10-K
WITH THE U.S. SEC- SEC FILING
* REVIVA PHARMACEUTICALS- EXPECTS TO REPORT RELATED MATERIAL
WEAKNESS IN ITS INTERNAL CONTROLS OVER FINANCIAL REPORTING & ITS
DISCLOSURE CONTROLS
Source text for Eikon: [ID:https://bit.ly/3xmHUlh]
Further company coverage: RVPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture